The J.D. Power 2022 U.S. Telehealth Satisfaction Study released today shows a stark increase in consumers preferring telehealth visits over in-person appointments for a broad range of routine care.
The study finds that 67% of survey respondents relayed they have accessed video telehealth services during the past year. Before the pandemic in 2019, that number was 37%.
Among those who used...
Rippl, a company focused on providing mental health solutions to seniors with dementia and other cognitive conditions, launched with a $32 million seed round led by ARCH Venture Partners and General Catalyst.
GV, F-Prime Capital and Mass General Brigham Ventures also participated.
WHAT THEY DO
The company, led by Starbucks veteran Kris Engskov, said it will launch a care model offered by health...
XP Health, a company developing a digital-first vision benefits platform, raised $17.1 million in a Series A funding round led by HC9 Ventures, Valor Capital Group and ManchesterStory.
Additional investors include Core Innovation Capital, GSR Ventures, Canvas Ventures, Plug and Play, CameronVC, Ken Goulet, Kevin Hill, Jeff Epstein and Brett Rochkind. This recent funding round followed a $5.5...
This week Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies like AstraZeneca, Merck, Pfizer, Teva, Israel Biotech Fund and Amazon Web Services, announced the formation of a new startup company dubbed OMEC.AI.
OMEC.AI aims to build a computational platform using AI that can help researchers assess the clinical trial readiness of a drug...
Calif.-based DyAnsys, a medical device company specializing in the autonomous nervous system, announced Primary Relief, its percutaneous electrical nerve stimulator (PENS) system, received approval by the FDA to treat postoperative pain following cardiac surgery.
According to DyAnsys, the PENS system can be used for up to three days following cardiac surgery and, in a clinical trial, reduced...
Australian company Seer Medical received FDA 510(k) clearance for its at-home electroencephalograph (EEG) system, Seer Home, which helps providers diagnose epilepsy.
Seer Home’s EEG system enables patients to undergo week-long studies at home. Patients wear a device – the Seer Sense – around their shoulders with electrodes connected to the patient’s skull and chest to record brain (EEG) and...
JAMA Health Forum published a cross-sectional study suggesting that re-implementing licensure restrictions on out-of-state telemedicine, which were lifted due to the COVID-19 pandemic, would have the most significant effect on patients living near a state border, ones in rural locations, and ones receiving primary care or mental health treatment.
"Relaxation of state restrictions would likely...
A recent study published in PLOS One and conducted by Beth Israel Deaconess Medical Center researchers in Boston reveals virtual reality use during hand surgery led to significant reductions in intraoperative anesthetic without negatively impacting patient-reported outcomes.
In a small, eight-month randomized controlled trial, researchers evaluated 34 patients undergoing hand surgery and the...
Led by Ally Bridge Group and with the help of its existing shareholders, venture-backed Ceribell, Inc. has raised $50 million.
The funding was structured as an extension of its $53 million Series C raise, which was announced in April 2021.
WHAT IT DOES
Ceribell developed a rapid response electroencephalography (EEG) system to make diagnosing neurological patients more efficient. It says that its...
Calif.-based startup Curative offers COVID-19 testing and vaccination services throughout the U.S., but as testing needs have lessened, the company is shifting its focus to launching a new health plan.
Due to the course change, the company is laying off 109 employees in early November.
The company filed a Worker Adjustment and Retraining Notification Act notice with the state of California. WARN...